Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and Adolescents
Clinical trial NCT02621177 · COMPLETED
Trial details
- NCT number
- NCT02621177
- Sponsor
- SK Chemicals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2014-03-01
- Enrollment
- 385
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.